Literature DB >> 21859777

Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM).

José T Drost1, Ganiye Arpaci, Jan Paul Ottervanger, Menko Jan de Boer, Jim van Eyck, Yvonne T van der Schouw, Angela H E M Maas.   

Abstract

INTRODUCTION: Preeclampsia is a complication of pregnancy and a known risk factor for cardiovascular disease (CVD) later in a women's life. The best approach for prevention of CVD in affected young women is yet unclear. We sought to investigate the prevalence of cardiovascular risk factors in women at 10 years post preeclampsia in comparison with a reference group.
METHODS: Women with a history of early preeclampsia (exposed), DBP ≥ 90 mmHg with proteinuria ≥ 0.3 gram/24 h before 32 weeks of gestation, and an equal number of women after uncomplicated pregnancy (non-exposed) from the obstetric database of 1991-2007, were sent a questionnaire and invited for a cardiovascular screening programme.
RESULTS: The current study included 339 exposed women and 332 non-exposed women, 10 years post index-pregnancy. Systolic and diastolic blood pressures (SBP/DBP) were 127/86 mmHg versus 119/79 mmHg in the exposed and reference group respectively (p < 0.001). Exposure to early preeclampsia was associated with a threefold increased prevalence of hypertension (adjusted odds ratio (OR) 3.59, 95%CI 2.48-5.20). BMI and waist circumference were 26.9 kg/m(2) and 86.5 cm in the exposed group and 26.2 kg/m(2) (p = 0.07) and 83 cm (p = 0.001) in the non-exposed group. We found no differences in levels of glucose, lipids and CRP. Adjusted OR for the metabolic syndrome in women post preeclampsia was 2.18 (95% CI 1.34-3.52) compared with women in the reference group.
CONCLUSION: We found a high prevalence of hypertension in young women at 10 years post early preeclampsia. More research on the timing of cardiovascular screening in these high-risk women is needed.

Entities:  

Mesh:

Year:  2011        PMID: 21859777     DOI: 10.1177/1741826711421079

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  26 in total

1.  Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.

Authors:  Rebeccah A McKibben; Mahmoud Al Rifai; Lena M Mathews; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-12-29

2.  Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia.

Authors:  Anna E Stanhewicz; Lacy M Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

3.  Alterations in endothelin type B receptor contribute to microvascular dysfunction in women who have had preeclampsia.

Authors:  Anna E Stanhewicz; Sandeep Jandu; Lakshmi Santhanam; Lacy M Alexander
Journal:  Clin Sci (Lond)       Date:  2017-11-23       Impact factor: 6.124

4.  Preeclampsia and cognitive impairment later in life.

Authors:  Julie A Fields; Vesna D Garovic; Michelle M Mielke; Kejal Kantarci; Muthuvel Jayachandran; Wendy M White; Alissa M Butts; Jonathan Graff-Radford; Brian D Lahr; Kent R Bailey; Virginia M Miller
Journal:  Am J Obstet Gynecol       Date:  2017-03-18       Impact factor: 8.661

5.  Cardiovascular biomarkers in the years following pregnancies complicated by hypertensive disorders or delivered preterm.

Authors:  Lauren J Tanz; Jennifer J Stuart; Stacey A Missmer; Eric B Rimm; Jennifer A Sumner; Mary A Vadnais; Janet W Rich-Edwards
Journal:  Pregnancy Hypertens       Date:  2018-04-18       Impact factor: 2.899

6.  Long-term alterations in maternal plasma proteome after sFlt1-induced preeclampsia in mice.

Authors:  Egle Bytautiene; Nataliya Bulayeva; Geeta Bhat; Li Li; Kevin P Rosenblatt; George R Saade
Journal:  Am J Obstet Gynecol       Date:  2013-03-13       Impact factor: 8.661

7.  Effect of race/ethnicity on hypertension risk subsequent to gestational diabetes mellitus.

Authors:  Rhonda Bentley-Lewis; Camille Powe; Elizabeth Ankers; Julia Wenger; Jeffrey Ecker; Ravi Thadhani
Journal:  Am J Cardiol       Date:  2014-01-31       Impact factor: 2.778

8.  Pregnancy Complications and Later Development of Hypertension.

Authors:  Suttira Intapad; Barbara T Alexander
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-06-01

Review 9.  Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention.

Authors:  Deborah B Ehrenthal; Janet M Catov
Journal:  Curr Opin Cardiol       Date:  2013-09       Impact factor: 2.161

10.  Latency of preterm hypertensive disorders of pregnancy and subsequent cardiovascular complications.

Authors:  Joshua I Rosenbloom; Dustin Stwalley; Kathryn J Lindley; D Michael Nelson; Margaret A Olsen; Molly J Stout
Journal:  Pregnancy Hypertens       Date:  2020-05-31       Impact factor: 2.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.